Truist Securities Maintains Hold on Pediatrix Medical Group, Lowers Price Target to $16
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price target from $18 to $16.
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price target from $18 to $16.